© BMJ Publishing Group Ltd. 2026
Rheumatology from BMJ Journals
BMJ Group is excited to be at EULAR 2026, a key international conference where clinicians, researchers, healthcare professionals and thought leaders across the full spectrum of rheumatic and musculoskeletal health come together to share the latest advances in the field and to shape the future of patient care.
We are proud to support the rheumatology community through trusted evidence, high-quality research and practical clinical resources that help turn new knowledge into better decision-making in everyday practice. Our presence at EULAR reflects a continued commitment to connecting cutting-edge research with real-world clinical impact.
Visit us at stand S17 to explore our rheumatology journal portfolio, meet our editors, and discover how we can help you publish, share, and amplify your research.
Innovative research - Global perspectives - Clinical relevance - Trusted evidence - Open access content
Download your free digital copy of EULAR 2026: Editors' Picks now!
Follow us during the event via the hashtag #EULAR26
Rheumatology at BMJ Group
This digital collection features articles selected by our editors covering major themes discussed at the conference.
RMD Open
BMJ Group has expanded its journal offerings with the launch of BMJ Immunology and BMJ Connections Immunology. This move addresses the growing need for rigorous, globally accessible immunology research and reflects our commitment to advancing the field and its clinical applications worldwide.
These launches allow us to offer a suitable home for even more of the world’s medical research, with two new options now available for immunology researchers who would prefer to publish in a specialist journal rather than in one of our general medical journals.
Journal of Scleroderma and Related Disorders
Editors-in-Chief:
Prof. Marco Matucci-Cerinic, Vita Salute San Raffaele University, Italy
Prof. Masataka Kuwana, Nippon Medical School, Japan
An open access multidisciplinary, peer reviewed publication targeted to scientists and clinicians interested in systemic sclerosis, scleroderma, and other related autoimmune and fibrotic diseases.
BMJ Connections Rheumatology
Editor-in-Chief:
Dr Ai Lyn Tan, University of Leeds, UK
A new open access rheumatology journal publishing the full spectrum of robust, reproducible original research in rheumatic, connective tissue and musculoskeletal diseases.
The official journal of the World Scleroderma Foundation (WSF) and the European Scleroderma Trials and Research group (EUSTAR).
Recently launched journals in immunology
- 1.2 Journal Impact Factor; 3.7 CiteScore
LSM
RMD Open
Editor-in-Chief:
Prof. João Fonseca, University of Lisbon, Portugal
An open-access journal publishing high-quality peer-reviewed original research covering the full spectrum of musculoskeletal disorders, rheumatism and connective tissue diseases, including osteoporosis, spine and rehabilitation.
Lupus Science & Medicine®
Editors-in-Chief:
Prof. Jill Buyon, New York University, USA
Prof. Ronald van Vollenhoven, Amsterdam University, Netherlands
A global, peer-reviewed, open-access online journal that provides a central point for the publication of basic, clinical, translational, and epidemiological studies of all aspects of lupus and related diseases.
Introducing our latest journals in rheumatology
An official journal of the Lupus Foundation of America (LFA)
- Journal Impact Factor: 4.8 and CiteScore: 7.6
- Median time from acceptance to publication: 22 days
- 20% acceptance rate
- 398,832 article views; 1,912 Altmetric mentions (2025)
- Trusted expertise, rigorous peer review and author support
- Journal Impact Factor: 4; CiteScore: 6.4
- Median time from acceptance to publication: 21 days
- 36% acceptance rate
- 154,550 article views; 420 Altmetric mentions (2025)
- Trusted expertise, rigorous peer review and author support
NOW OPEN FOR SUBMISSIONS
The journal accepts submissions of a wide range of article types, including original research, reviews, protocols and opinion.
